Period: 2007-2009
Region: Russia
Region: Russia
Quotation from the Report:
"... Industrial-scale production of probiotics is currently established in Russia alongside with the production of an ‘expressed’ synbiotic (“Provagen”), combining effects of both probiotics and prebiotics at the expense of a lactose carrier. However, it is impossible to draw a distinction between probiotics and synbiotics, as some probiotics, employing such vegetative substances as beet molasses (“Monosporin”), bran (“Cellobacterin”) and schrot (“Bacell”) as carriers, also facilitate growth of normal microflora, i.e., produce a prebiotic effect.
Production of probiotics started not so long ago – in the early 2000. Nevertheless, the current manufacturers are producing a wide range of preparations, based on a variety of active components in different forms and concentrations. The highest market value is attributed to medium concentration preparations with titers 107 and 108 and preparations with titer 109, belonging to the group of concentrates.
Normally, preparations with the concentration of up to 108 inclusive are used as feed additions and are less popular as therapeutic agents. Advantage of lower concentration preparations, used as permanent feed additions, are explained by two factors: substrates, representing natural components of fodder (schrot, bran, molasses) are used as carriers, which ensures a more homogeneous distribution of the preparation and allows one to vary its administration doses. In addition to this, in some cases their use is more cost efficient.
Among the feed additions preparations like “Bacell” and “Cellobacterin”, combing probiotic and enzymatic activity, deserve a special mentioning.
As of 2009 the volume of domestic probiotic production is estimated to be 1000 tons..."
Content
Research Modalities
1. General characteristics of preparations for optimization of microflora of farm animals
2. Domestic production of eubiotics
2.1 Basic features of domestic production. Range of preparations.
2.2. Domestic production
Domestic production of eubiotics in natural terms.
Pattern of production of eubiotics in terms of concentration of microorganisms.
Price analysis
Domestic production of eubiotics and financial crisis
3. Export of eubiotics
4. Import of eubiotics
4.1. Dynamics of volume and pattern of eubiotics import
4.2. The pattern of import from the viewpoint of major groups and brands of eubiotics
4.3. Rating of the leading eubiotics importers
4.4. Rating of the leading manufacturers of the imported eubiotics
5. Market for eubiotics
5.1. Eubiotics market volume dynamics
5.2. Eubiotics market structure
6. Prospects of market expansion for preparations, improving the microflora of gastrointestinal tract of farm animals
6.1. Prospects for various groups of preparations
Efficiency of probiotics
Efficiency of prebiotics
Efficiency of synbiotics
Efficiency of synbiotic acidifiers
The place of eubiotics in the complex of means, replacing feed antibiotics
6.2. Prospects for the RF eubiotic market
7. Prospects for the production of eubiotics based on agroindustrial complex by-products
Attachment 1. Leading Companies’ Profiles
LLC “Biotorf”
LLC “Biotekhagro”
CJSC “Trionis”
LLC “RI of Probiotics”
Biotechnology company “Component”
LLC “RPC “Research Center”
Alltech Ltd.
Kemin Europa N.V.
Daavision B.V.
